Oregon Oncology COVID 19

Viewing Page 1 of 1 | Showing Results 1 - 3 of 3

A Phase III, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Patients With Severe COVID-19 Pneumonia

This study will evaluate the efficacy and safety of combination therapy with remdesivir plus tocilizumab compared with remdesivir plus placebo in...

Jason Wells, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

A PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MSTT1041A OR UTTR1147A IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA

This is a Phase II, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of MSTT1041A (astegolimab) or...

Jason Wells, M.D.
  • Providence Portland Medical Center

RWF 20-003312 - Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19

This expanded access program will provide access to investigational convalescent plasma for patients in acute care facilities infected with...

Stacy Lewis, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
Viewing Page 1 of 1 | Showing Results 1 - 3 of 3